Agenda

2024 Agenda - Coming Soon

Anticipated Agenda Outline (for travel planning)

*A detailed 2024 agenda is under development.  Please check back for updates.

  • Thursday April 25th -  7am - 5pm - Didactics
  • Friday April 26th -  7am - 5pm - Didactics
  • Saturday April 27th -  7am - 1pm - Didactics

2023 Agenda

*2023 Displayed for reference.  Please check back for updates.

  • 6:30-7:00 AM - Breakfast/Registration
  • 7:00-7:15 AM - Welcome - Glenn LaMuraglia
  • 7:15-7:30 AM - How low should the cholesterol be targeted and how to get it there - Janet Lo
  • 7:30-7:45 AM - What are the predictors of MI after vascular surgery; how to best evaluate and manage the patient to avoid it? - Eric Isselbacher
  • 7:45-8:00 AM - Hx DVT and recurrent bypass thrombosis suggesting thrombophilia, how should they be further evaluated? - Hanny Al-Samkari
  • 8:00-8:15 AM - The smoking vascular patient tobacco/weed/vape;  what are the effects and how to help them stop - Nancy Rigotti
  • 8:15-8:30 AM - The new oral anticoagulants, how good are they and should they be used to treat athero-obstructive disease? - Michael Jaff
  • 8:30-8:45 AM - In atherosclerotic disease, is aspirin still the gold standard, or are other antiplatelets drugs better - Robert Schainfeld
  • 8:45-9:00 AM - The bleeding patient: How to prevent bleeding and approach the treatment of the bleeding patient - J Taylor Lloyd
  • 9:00-9:15 AM - Evaluation and management of non-inflammatory vascular findings on CTA (fibromuscular dysplasia, local dissections, webs) - Gaurav Parmar
  • 9:15-9:30 AM - Panel
  • 9:30-10:00 AM - Coffee & Snack Break

OCCLUSIVE DISEASE I

  • 10:00-10:15 AM - What is the role of exercise in PAD, is it different for severe claudicators? - Ido Weinberg
  • 10:15-10:30 AM - How does gender and age affect short and long term outcomes for LE revascularization? - Luis Suarez
  • 10:30-10:45 AM - Longevity in patients with LE occlusive disease, how does it affect my decision on how to treat their disease? - David Stone
  • 10:45-11:00 AM - What are the optimal conduit options when ipsilateral GSV is not present? - Alan Hamdan
  • 11:00-11:15 AM - New chronic total occlusion devices and Drug eluting stent/balloon, what works, what are the risks and is it worth the cost? - Jocelyn Beach
  • 11:15-11:30 AM - Debate: Femoral endarterectomy or bypass is the best way to treat common femoral occlusive disease - Jeffery Siracuse
  • 11:30-11:45 AM - Debate: Avoid the groin complications, endo is the best way to treat common femoral occlusive disease - Douglas Drachman
  • 11:45 AM-12:00 PM - Panel
  • 12:00-1:00 PM - Lunch On Your Own

ANEURYSM I

  • 1:00-1:15 PM - Aortic ulcers, focal dissections, intramural hematoma, what are the current recommendations? - Eric Isselbacher
  • 1:15-1:30 PM - Inhibiting small Aneurysm growth: Metformin, Ticagrelor and other approaches - Patric Liang
  • 1:30-1:45 PM - Contemporary SVS guidelines for AAA, should there be a gender, growth rate and age consideration? - Lars Stangenberg
  • 1:45-2:00 PM - Current available predictive models of AAA outcomes, how they predict risk and help decisions to Rx patient AAA - David Stone
  • 2:00-2:15 PM - Although IFU are important for EVARs, which ones have the least impact on EVAR failure? - Laura Boitano
  • 2:15-2:30 PM - With the availability of fenestrated devices, when is justified to use to used chimneys/snorkels? - Jessica Simons

  • 2:30-2:45 PM - Panel

  • 2:45-3:15 PM - Coffee & Snack Break
VENOUS DISEASE
  • 3:15-3:30 PM - Acute DVT management, what are the options and when should you treat with thrombolysis - Zubin Irani
  • 3:30-3:45 PM - The post thrombotic limb: what is the supra and infrainguinal management of chronic deep venous thrombosis - Chieh-Min Fan
  • 3:45-4:00 PM - Approaches to the symptomatic patient with recurrent venous disease, what are the best options? - Sherry Scovell
  • 4:00-4:15 PM - Complications of trunkal venous ablation and contemporary practice methods to avoid them - Dejah Judelson
  • 4:15-4:30 PM - Debate: The novel non-thermal venous ablation methods are best tolerated and provide excellent results - Sherry Scovell
  • 4:30-4:45 PM - Debate: Forget foam, glue and MOCA, thermal venous ablation provides the best results at the lowest cost - Thomas O'Donnell
  • 4:45-5:45 PM - Problem Case Presentation - Chuck DeCarlo; Sam Jessula; Anna Alaska Pendleton
  • 5:45-6:45 PM - Cocktails & Hors D'oeuvres